| 1 | Study | 2.34% | |
| 2 | New | 1.4% | |
| 3 | Cancer | 1.4% | |
| 4 | Asia | 1.4% | |
| 5 | Kidney | 0.93% | |
| 6 | Screens | 0.93% | |
| 7 | Patients | 0.93% | |
| 8 | Safety | 0.93% | |
| 9 | Therapy | 0.93% | |
| 10 | Artery | 0.93% | |
| 11 | Pacific | 0.93% | |
| 12 | Cell | 0.93% | |
| 13 | Era | 0.93% | |
| 14 | Access | 0.47% | |
| 15 | Boosts | 0.47% | |
| 16 | LivaNova’s | 0.47% | |
| 17 | Some | 0.47% | |
| 18 | Pathogen | 0.47% | |
| 19 | Effectively | 0.47% | |
| 20 | Strategies | 0.47% | |
| 21 | Endocrine | 0.47% | |
| 22 | Cardiobacterium | 0.47% | |
| 23 | Approval | 0.47% | |
| 24 | Effectiveness | 0.47% | |
| 25 | Risk | 0.47% | |
| 26 | Resistance | 0.47% | |
| 27 | Day | 0.47% | |
| 28 | Detection | 0.47% | |
| 29 | NR2F2 | 0.47% | |
| 30 | Dental | 0.47% | |
| 31 | Fibrosis | 0.47% | |
| 32 | Sabah | 0.47% | |
| 33 | Infection | 0.47% | |
| 34 | Predicts | 0.47% | |
| 35 | Inhibitor | 0.47% | |
| 36 | CooperVision | 0.47% | |
| 37 | Transplant | 0.47% | |
| 38 | Could | 0.47% | |
| 39 | Valve | 0.47% | |
| 40 | Swiss | 0.47% | |
| 41 | Title | 0.47% | |
| 42 | Enzyme | 0.47% | |
| 43 | Dengue’ | 0.47% | |
| 44 | Nanoparticle | 0.47% | |
| 45 | Dissection | 0.47% | |
| 46 | Regulator | 0.47% | |
| 47 | Adherence | 0.47% | |
| 48 | UConn | 0.47% | |
| 49 | Validates | 0.47% | |
| 50 | Drug | 0.47% | |
|
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
|||